Quest for the right Drug

|
עמוד הבית / עזרקאין זריקות % 1 / מידע מעלון לרופא

עזרקאין זריקות % 1 ESRACAIN INJECTION 1% (LIDOCAINE HYDROCHLORIDE)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

תוך-שרירי, אפידורל, תת-עורי, תוך-עורי, הזרקה תת-רירית, שדרתי, לסביבת העצב, : I.M, EPIDURAL, S.C, INTRADERMAL, SUBMUCOSAL, SPINAL, PERINEURAL, I.V REGIONAL ANAESTHESIA

צורת מינון:

תמיסה להזרקה : SOLUTION FOR INJECTION

Adverse reactions : תופעות לוואי

4.8 Undesirable effects

General

The frequency and severity of the undesirable effects of lidocaine depend upon the dose, the method of administration and the patient's individual sensitivity.

Symptoms of local toxicity may occur after the administration of lidocaine. Systemic adverse effects may be expected at plasma concentrations of lidocaine exceeding 5-10 mg/l. They become manifest in the form of both CNS symptoms and cardiovascular symptoms (see also section 4.9).

The possible undesirable effects after administration of lidocaine as local anaesthetic are largely the same as those produced by other amide-type local anaesthetics.

Listing of undesirable effects
Definition of frequency terms used in this section:

Very common: (> 1/10)
Common: (> 1/100 to < 1/10)
Uncommon: (> 1/1,000 to < 1/100)
Rare: (> 1/10,000 to < 1/1,000)
Very rare (< 1/10,000)
Not known (frequency cannot be estimated from the available data)
Local and regional anaesthesia

Blood and the lymphatic system disorders
Not known: Methemoglobinemia

Immune system disorders
Rare: Anaphylactic reactions manifesting as urticaria, oedema, bronchospasm, respiratory distress and circulatory symptoms up to anaphylactic shock.

Nervous system disorders
Common: Transient neurological symptoms especially pain after spinal and epidural anaesthesia- (up to 5 days).
Rare: Neurological complications following central nervous blocks - mainly spinal anaesthesia - such as persistent anaesthesia, paraesthesia, paresis up to paraplegia, Cauda equina syndrome (i.e. bilateral leg weakness up to paraplegia, saddle anaesthesia, urinary retention and fecal incontinence), headache accompanied by tinnitus and photophobia
Cranial nerve lesions, neurosensory deafness (if administered in head and neck regions).
Horner's syndrome, associated with epidural anaesthesia or regional applications in the head/neck region.

Gastrointestinal disorder
Very common: Nausea, vomiting


Injury, poisoning and procedural complications
Rare: Trauma, transient radicular irritation due to spinal anaesthesia, compression of the spinal cord after development of haematoma
General disorders and administration site conditions
Rare: Shivering (after epidural use)

Information on particular undesirable effects
None

Paediatric population
Frequency, type and severity of adverse reactions in children are expected to be the same as in adults.
Elderly patients
In elderly patients the incidence of undesirable effects may be increased (see section 4.4).

Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form:  https://sideeffects.health.gov.il/

שימוש לפי פנקס קופ''ח כללית 1994 לא צוין
תאריך הכללה מקורי בסל 01/01/1995
הגבלות תרופה שאושרה לשימוש כללי בקופ'ח

בעל רישום

RAFA LABORATORIES LTD

רישום

019 20 21029 00

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

12.05.22 - עלון לרופא 22.12.23 - עלון לרופא

עלון מידע לצרכן

12.05.22 - החמרה לעלון 22.12.23 - החמרה לעלון

לתרופה במאגר משרד הבריאות

עזרקאין זריקות % 1

קישורים נוספים

RxList WebMD Drugs.com